UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Eagle Bancorp
EGBN
$843M
| $706K | ﹤0.01% |
34,930
-54,700
| -61% | -$1.06M |
|
2102
Skillsoft
SKIL
$83.5M
| $706K | ﹤0.01% |
54,238
| – | – |
|
2103
Business First Bancshares
BFST
$1.03B
| $701K | ﹤0.01% |
29,703
-34,507
| -54% | -$854K |
|
2104
MetroCity Bankshares
MCBS
$1.02B
| $697K | ﹤0.01% |
25,172
-26,607
| -51% | -$773K |
|
2105
Evolus
EOLS
$500M
| $694K | ﹤0.01% |
112,966
-62,593
| -36% | -$488K |
|
2106
Covenant Logistics
CVLG
$843M
| $689K | ﹤0.01% |
31,831
-20,469
| -39% | -$489K |
|
2107
NB Bancorp
NBBK
$989M
| $689K | ﹤0.01% |
39,025
-54,360
| -58% | -$997K |
|
2108
RUM Group Inc
RUM
$1.71B
| $688K | ﹤0.01% |
95,077
-88,147
| -48% | -$720K |
|
2109
StoneCo
STNE
$2.52B
| $686K | ﹤0.01% |
36,300
-74,032
| -67% | -$1.18M |
|
2110
Peapack-Gladstone Financial
PGC
$800M
| $681K | ﹤0.01% |
24,675
-18,615
| -43% | -$522K |
|
2111
South Plains Financial
SPFI
$838M
| $677K | ﹤0.01% |
17,508
-14,574
| -45% | -$569K |
|
2112
First Community Bankshares
FCBC
$902M
| $673K | ﹤0.01% |
19,346
-19,349
| -50% | -$732K |
|
2113
PACS Group
PACS
$7.67B
| $668K | ﹤0.01% |
48,618
-62,140
| -56% | -$729K |
|
2114
Standard BioTools
LAB
$310M
| $667K | ﹤0.01% |
512,708
-230,964
| -31% | -$303K |
|
2115
Spyre Therapeutics
SYRE
$9.29B
| $662K | ﹤0.01% |
39,498
-46,204
| -54% | -$753K |
|
2116
Aspen Aerogels
ASPN
$521M
| $658K | ﹤0.01% |
94,589
-88,720
| -48% | -$626K |
|
|
CVGW
2117
DELISTED
Calavo Growers
CVGW
| $649K | ﹤0.01% |
25,197
-31,753
| -56% | -$857K |
|
2118
Atlanta Braves Holdings Series A
BATRA
$3.42B
| $648K | ﹤0.01% |
14,257
+7,481
| +110% | +$354K |
|
2119
New Fortress Energy
NFE
$97.8M
| $641K | ﹤0.01% |
290,154
-109,077
| -27% | -$310K |
|
|
TRML
2120
DELISTED
Tourmaline Bio
TRML
| $621K | ﹤0.01% |
12,987
-3,916
| -23% | -$109K |
|
2121
Shutterstock
SSTK
$217M
| $618K | ﹤0.01% |
29,623
-36,640
| -55% | -$747K |
|
2122
Dr. Reddy's Laboratories
RDY
$10.1B
| $612K | ﹤0.01% |
43,754
-4,268
| -9% | -$61.4K |
|
2123
Accel Entertainment
ACEL
$978M
| $608K | ﹤0.01% |
54,952
-56,811
| -51% | -$664K |
|
2124
RPC Inc
RES
$1.36B
| $599K | ﹤0.01% |
125,903
-123,514
| -50% | -$583K |
|
2125
FRP Holdings
FRPH
$415M
| $597K | ﹤0.01% |
24,492
-26,346
| -52% | -$685K |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.